<DOC>
	<DOCNO>NCT01610115</DOCNO>
	<brief_summary>To elucidate natural course chronic hepatitis B serial HBV DNA alanine aminotransferase ( ALT ) level pregnancy</brief_summary>
	<brief_title>HBV DNA Levels During Pregnancy Chronic Hepatitis B</brief_title>
	<detailed_description>This prospective observational follow-up study single center . Number patient : It estimate enroll 100 patient Taiwan . Population : Female patient pregnancy confirm , least 20 year age diagnose chronic hepatitis B . The patient able communicate well , provide informed consent willing participate entire study . Inclusion criterion : Patients must meet follow criterion 1 . Documented chronic hepatitis B define clinical history compatible chronic hepatitis B detectable serum HBsAg 2 . Female 20 year age confirm pregnancy 3 . Willing able comply requirement observational followup study 4 . Willing able provide write informed consent participate study Exclusion criterion : Patients exclude study follow reason : 1 . Concurrent infection hepatitis C virus ( HCV ) , hepatitis D virus ( HDV ) human immunodeficiency virus ( HIV ) 2 . One know primary secondary cause liver disease hepatitis B ( e.g. , alcoholism , non-alcoholic steatohepatitis , autoimmune hepatitis , malignancy hepatic involvement , hemochromatosis , alpha-1 antitrypsin deficiency , Wilson 's disease , congenital metabolic condition affect liver , congestive heart failure severe cardiopulmonary disease ) . 3 . Any concurrent medical psychosocial condition likely preclude compliance schedule evaluation protocol likely confound efficacy safety observation study . 4 . Enrolled planning enroll another clinical trial investigational agent participate study . 5 . Patients antiviral therapy chronic hepatitis B</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<criteria>1 . Documented chronic hepatitis B define clinical history compatible chronic hepatitis B detectable serum HBsAg 2 . Female 20 year age confirm pregnancy 3 . Willing able comply requirement observational followup study 4 . Willing able provide write informed consent participate study 1 . Concurrent infection hepatitis C virus ( HCV ) , hepatitis D virus ( HDV ) human immunodeficiency virus ( HIV ) 2 . One know primary secondary cause liver disease hepatitis B ( e.g. , alcoholism , nonalcoholic steatohepatitis , autoimmune hepatitis , malignancy hepatic involvement , hemochromatosis , alpha1 antitrypsin deficiency , Wilson 's disease , congenital metabolic condition affect liver , congestive heart failure severe cardiopulmonary disease ) . 3 . Any concurrent medical psychosocial condition likely preclude compliance schedule evaluation protocol likely confound efficacy safety observation study . 4 . Enrolled planning enroll another clinical trial investigational agent participate study . 5 . Patients antiviral therapy chronic hepatitis B</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Pregnancy</keyword>
</DOC>